After you establish a data sharing† connection with your patients, you can access insightful glucose reports and metrics, enabling more productive conversations and more informed treatment decisions.
After you establish a data sharing† connection with your patients, you can access insightful glucose reports and metrics, enabling more productive conversations and more informed treatment decisions.
LibreView reports include:
Ambulatory Glucose Profile (AGP) Report
Using the AGP Report, you can make Time in Range (TIR) the standard of care when making treatment and dosing decisions for your patients.
AGP Report with TIR: Developed to align with the International Consensus on TIR standards2
For illustrative purposes only. Not actual patient data.
For illustrative purposes only. Not actual patient data.
Powered by LibreView*, the GPI report provides a guided interpretation of your patients’ continuous glucose monitoring (CGM) data.
You can:
Shows glucose levels, carbohydrate intake data, and insulin administration data over a “typical” or average day during the reporting period
For illustrative purposes only. Not actual patient data.
For illustrative purposes only. Not actual patient data.
Provides a daily glucose summary for each day of the selected reporting period
Shows past glucose results to facilitate discussion with patients, in addition to:
* The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
† The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
‡ Default range is 70-180 mg/dL. Consult with a healthcare professional on individual target glucose range.
References: 1. Unger, Jeff, Pamela Kushner, and John E. Anderson. "Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care." Postgraduate Medicine 132, no. 4 (2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393. 2. Battelino, Tadej, et al. "Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on Time in Range." Diabetes Care 42, no. 8 (2019): 1593-1603. https://doi.org/10.2337/dci19-0028.
ADC-52574 v2.0
Important Safety Information
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v19.0
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
